細胞サイクルの持続時間は,腫瘍性変容能力を決定する
Danian Chen1,2,3,4, Suying Lu1, Katherine Huang1
1Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
Nature
|April 30, 2025
まとめ
細胞サイクルの総持続時間 (Tc) は,がんの感受性を予測する. 短いTcは,がんに罹患しやすい細胞系統を特定し,変異した細胞がどのように変異から逃れ,正常な腫瘍抑制メカニズムに抵抗するかを説明します.
科学分野:
- 腫瘍学
- 細胞生物学
- 癌 の 遺伝子
背景:
- がん発生性突然変異は正常な組織に多く見られるが,がんは必ずしも発生しない.
- 変異した細胞が 変異しない理由を理解することは 癌の予防に不可欠です
研究 の 目的:
- 癌に罹患しやすい細胞と 癌に耐える細胞を区別する 特徴を特定する
- 細胞サイクルの長さが癌の感受性を予測するかどうかを判断する.
主な方法:
- 様々ながんモデルにおける細胞サイクル期間 (Tc) の分析.
- Rbとp107欠乏した網膜細胞の癌の特徴を調べる
- SKP2-p27-CDK2/CDK1軸を混乱させる
主要な成果:
- 細胞サイクル総長 (Tc) は,複数の腫瘍タイプにおける変異感受性を一貫して予測します.
- 癌に罹患しやすい系統は アポトーシス,老化,免疫監視の欠陥を示します
- 最短のTcは,変異のタイミングに関係なく,Rb- pituitaryと肺がんのモデルで起源の細胞を特定しました.
結論:
- 相対的な細胞サイクル期間は,がんの発症の重要な特徴です.
- 短いTcは,がんに罹患しやすいとがんに抵抗する系統を区別し,腫瘍抑制メカニズムからの脱出を説明します.
- ガン発症には 単に腫瘍変異があるだけでは 十分ではありません
関連する概念動画
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
What is the Cell Cycle?
6.3K
The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: the interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the...
6.3K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Molecular Factors Affecting Cell Division
2.9K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
2.9K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


